Monitor the next quarterly report for any signs of operational disruption or financial reporting quality under the new interim CFO. The transition appears smooth, so no near-term trading catalyst from this change alone.
Price Chart
Executive Summary
Profound Medical announced the resignation of CFO Rashed Dewan and the appointment of Corporate Controller Matthew Sobczyk as Interim CFO, effective August 14, 2026. The CFO departure is orderly with a transition consulting agreement, and the interim CFO is an internal promotion with deep company knowledge, making this a routine management change with no immediate financial impact on operations.
Key Facts
- CFO Rashed Dewan resigned effective August 14, 2026.
- Matthew Sobczyk, previously Corporate Controller, appointed Interim CFO effective same date.
- Dewan will serve as a consultant from August 17 to November 25, 2026, receiving CAD 200/hour + continued vesting of 20,000 RSUs.
- Dewan receives a $375,000 cash severance payment.
- Sobczyk's annual base salary set at CAD 300,414.58 with a 15% target bonus.
- No financial guidance, preliminary results, or revenue/earnings data were disclosed.
Financial Impact
CFO severance payment of $375,000; no impact on revenue, earnings, or operations disclosed.
Risk Factors
- Extended CFO vacancy could signal deeper organizational issues if a permanent replacement is not named within months.
- Loss of institutional knowledge if the consulting transition period is insufficient.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001171843-26-005575 |
| Exhibit: exh_991.htm | 0001171843-26-005575 |
| Document: 0001171843-26-005575-index-headers.html | 0001171843-26-005575 |
| Document: 0001171843-26-005575-index.html | 0001171843-26-005575 |
| Document: 0001171843-26-005575.txt | 0001171843-26-005575 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | 8-K | $6.89 $5.81 | ▼ −15.67% | ▼ −14.47% | $5.85 (−15.09%) |
Sep 3, 2026 29d ago | 8-K | $6.80 $5.97 | ▼ −12.21% | ▼ −11.06% | $5.85 (−13.97%) |
Aug 17, 2026 6w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.85 (−10.69%) |
Aug 17, 2026 6w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.85 (−10.69%) |
Jul 24, 2026 10w ago | 8-K | $7.26 $7.25 | ▼ −0.14% | ▼ −0.51% | $5.85 (−19.42%) |
Jul 15, 2026 11w ago | 8-K | $6.96 $6.99 | ▲ +0.43% | ▲ +1.41% | $5.85 (−15.95%) |
May 14, 2026 20w ago | 8-K | $6.97 $6.83 | ▼ −2.01% | ▼ −2.97% | $5.85 (−16.07%) |
May 12, 2026 20w ago | S-3 | $7.10 $6.73 | ▼ −5.21% | ▼ −4.05% | $5.85 (−17.61%) |
Apr 16, 2026 24w ago | 8-K | $6.62 $6.75 | ▲ +1.96% | ▲ +0.98% | $5.85 (−11.63%) |
Apr 14, 2026 24w ago | 8-K | $6.26 $6.84 | ▲ +9.27% | ▲ +7.87% | $5.85 (−6.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access